`

Tonix Pharmaceuticals

Pharmaceutical Manufacturing

Last Updated: November 20, 2025
Sign Up to View More
Revenue
$5.50M
funding-icon Total Funding
$4.4M
Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs
Recent News

Frequently Asked Questions About Tonix Pharmaceuticals

What does Tonix pharmaceuticals do?+

Tonix is a biopharmaceutical company, publicly traded on NASDAQ (ticker: TNXP). The Company is focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease. Tonix markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg. Zembrace SymTouch and Tosymra are each indicated for the treatment of acute migraine with or without aura in adults. Tonixs development portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonixs CNS development portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. The Companys...

What is Tonix pharmaceuticals's industry? +

Tonix pharmaceuticals operates in the Pharmaceutical manufacturing industry.

What is Tonix pharmaceuticals's revenue? +

Tonix pharmaceuticals's revenue is $5.50m

What is Tonix pharmaceuticals's company size? +

Tonix pharmaceuticals has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free